Jaguar health regains compliance with nasdaq's bid price requirement

Jagx's securities continue to be listed on nasdaq san francisco, ca / accesswire / february 8, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that on february 7, 2023 the company received formal notice from the nasdaq stock market llc ("nasdaq") that jaguar has regained compliance with nasdaq's minimum bid price requirement. "we are very happy that jaguar has regained compliance with nasdaq," said lisa conte, jaguar's president and ceo, "and we are concentrating on two late-stage clinical events in the next approximately 6 months that we expect to be transformational in terms of value creation and recognition for the company.
JAGX Ratings Summary
JAGX Quant Ranking